The Imperative of Equal Funding for Studies That Evaluate Any of the Evidence-Based, Guideline-Recommended Colorectal Cancer Screening Tests

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 12, 2009, Pages 1269-1271

  Allison, James E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC KIT; EDITORIAL; EVIDENCE BASED MEDICINE; OCCULT BLOOD; PRACTICE GUIDELINE; SIGMOIDOSCOPY;

AGED; CAPITAL FINANCING; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; MIDDLE AGED;

EID: 70949084148     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.08.007     Document Type: Editorial

References (29)

1. Byers T., Levin B., Rothenberger D., et al. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. CA Cancer J Clin 47 (1997) 154-160
2. Winawer S.J., Fletcher R.H., Miller L., et al. Colorectal cancer screening: clinical guidelines and rationale [errata appear in Gastroenterology 1997;112:1060 and 1998;114:625]. Gastroenterology 112 (1997) 594-642
3. Davila R.E., Rajan E., Baron T.H., et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 63 (2006) 546-557
4. Rex D.K., Johnson D.A., Lieberman D.A., et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 95 (2000) 868-877
5. Levin B., Lieberman D.A., McFarland, et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134 (2008) 1570-1595
6. Screening for Colorectal Cancer. US Preventive Services Task Force Recommendation Statement. Ann Intern Med 149 (2008) 627-637
7. Lieberman D.A., and Weiss D.G. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345 (2001) 555-560
8. Gondal G., Grotmol T., Hofstad B., et al. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 38 (2003) 635-642
9. Kato J., Morikawa T., Kuriyama M., et al. Combination of sigmoidoscopy and a fecal immunochemical test to detect proximal colon neoplasia. Clin Gastroenterol and Hepatol 7 (2009) 1341-1346
10. Pickhardt P.J., Nugent P.A., Mysliwiec P.A., et al. Location of adenomas missed by optical colonoscopy. Ann Intern Med 141 (2004) 352-359
11. Baxter N.N., Goldwasser M.A., Paszat L.F., et al. Association of colonoscopy and death from colorectal cancer: a population-based case control study. Ann Intern Med 150 (2009) 1-8
12. Lakoff J., Paszat L.F., Saskin R., et al. Risk of developing proximal vs distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 6 (2008) 1117-1121
13. Singh H., Turner D., Xue L., et al. Risk of developing colorectal cancer following a negative colonoscopy examination. JAMA 295 (2006) 2411-2412
14. Zauber A.G., Lansdorp-Vogelaar I., Knudsen A.B., et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force. Ann Intern Med 149 (2008) 659-669
15. U.S. Preventive Services Taskforce Screening for Colorectal Cancer. U.S. Preventive Services Taskforce Recommendation Statement. Ann Intern Med 149 (2008) 627-647
16. Rex D., Johnson D.A., Anderson J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 104 (2009) 739-750
17. Podolsky D.K. Going the distance-the case for true colorectal-cancer screening. N Engl J Med 343 (2000) 207-208
18. Osborn N.K., and Ahlquist D.H. Stool screening for colorectal cancer; molecular approaches. Gastroenterology 128 (2005) 192-206
19. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an averagerisk population. N Engl J Med 351 (2004) 2704-2714
20. Ahlquist D.A., Sargent D.J., Loprinzi C.L., et al. Stool DNA versus occult blood testing stool DNA and occult blood testing for screen detection of colorectal neoplasia: a prospective multicenter comparison. Ann Intern Med 149 (2008) 441-450
21. Morikawa T., Kato J., Yamaji Y., et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129 (2005) 422-428
22. Allison J.E., Sakoda L.C., Levin T.R., et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99 (2007) 1-9
23. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
24. Kronborg O., Fenger C., Olsen J., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996) 1467-1471
25. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328 (1993) 1365-1371
26. Mandel J.S., Church T.R., Bond J.H., et al. The effect of fecal occultblood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000) 1603-1607
27. Selby J.V., Friedman G.D., Quesenberry Jr. C.P., et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326 (1992) 653-657
28. Lewis J.D., and Asch D.A. Barriers to office-based screening sigmoidoscopy, does reimbursement cover costs?. Ann Intern Med 130 (1999) 525-530
29. Shaheen N.J., and Ransohoff D.F. Sigmoidoscopy costs and the limits of altruism. Am J Med 107 (1999) 286-287